Tramadol Should Be Avoided During Pregnancy
Tramadol should not be used during pregnancy due to significant safety concerns, including FDA warnings against use prior to or during labor, evidence of placental transfer, and risks of neonatal withdrawal syndrome. 1
Key Safety Concerns
FDA Drug Label Warnings
The FDA explicitly states that tramadol hydrochloride should not be used in pregnant women prior to or during labor unless potential benefits outweigh the risks 1. Critical concerns include:
- Placental transfer: Tramadol crosses the placenta with a mean umbilical vein to maternal vein ratio of 0.83 1
- Chronic use risks: Physical dependence and post-partum withdrawal symptoms in newborns 1
- Post-marketing reports: Neonatal seizures, neonatal withdrawal syndrome, fetal death, and stillbirth 1
- Unknown long-term effects: The impact on later growth, development, and functional maturation of the child remains unstudied 1
Clinical Evidence on Pregnancy Outcomes
The research evidence presents mixed findings but raises important concerns:
Spontaneous abortion risk: One French database study found a nearly 2-fold increased risk of spontaneous pregnancy termination with tramadol exposure (adjusted HR 1.86 compared to unexposed women, 2.23 compared to codeine-exposed women) 2. However, a Danish cohort study found no increased risk (HR 1.06,95% CI 0.99-1.14) 3.
Congenital malformations: The evidence is conflicting:
- A Swedish registry study of 1,751 exposed pregnancies found a modestly increased risk of relatively severe malformations (adjusted OR 1.33,95% CI 1.05-1.70), with specific increases in cardiovascular defects (OR 1.56) and clubfoot/pes equinovarus (OR 3.63) 4
- The Danish study found no increased risk (RR 1.04,95% CI 0.87-1.24) 3
- The French study similarly found no association (adjusted OR 1.24,95% CI 0.86-1.79) 2
Neonatal Withdrawal Syndrome
Neonatal abstinence syndrome is a well-documented risk with chronic tramadol use during pregnancy. Case reports demonstrate withdrawal symptoms developing 36 hours after delivery, requiring treatment with phenobarbital for up to 9 days 5. This represents a serious clinical concern requiring neonatal monitoring and potential pharmacologic intervention.
Clinical Recommendations
During Pregnancy
Avoid tramadol entirely during pregnancy. If a pregnant woman presents already taking tramadol:
- Do not initiate tramadol for new pain complaints during pregnancy
- For chronic pain patients on tramadol: Consider transitioning to safer alternatives under specialist guidance, though abrupt discontinuation should be avoided due to withdrawal risks
- If tramadol use is unavoidable: Use the lowest effective dose for the shortest duration possible, with full informed consent about risks
Alternative Pain Management
Prioritize non-opioid analgesics when possible:
- Acetaminophen remains the first-line analgesic during pregnancy (though recent evidence suggests using only when needed at lowest effective doses) 6
- NSAIDs may be considered in second trimester only (avoid in first and third trimesters)
- For severe pain requiring opioids: Morphine is preferred over tramadol if strong analgesia is required 7
Labor and Delivery
Tramadol is contraindicated for labor analgesia 1. For opioid-dependent women requiring pain management during labor, the 2019 joint SMFM/ACOG/ASAM guidelines recommend:
- Neuraxial analgesia (epidural or combined spinal-epidural) as the preferred modality 8
- Continuation of baseline medication-assisted treatment (methadone or buprenorphine) throughout labor 8
- Avoidance of opioid agonist/antagonists that can precipitate withdrawal 8
Breastfeeding Considerations
Tramadol should be used with extreme caution during breastfeeding, if at all. The 2020 Association of Anaesthetists guideline notes:
- Tramadol and its active metabolite O-desmethyltramadol are excreted in breast milk 7
- Case reports document respiratory depression and death in breastfed infants 7
- FDA issued a 2017 warning against tramadol use while breastfeeding 7
- If used, restrict to inpatient settings only with limited total dose and close infant monitoring for sedation, respiratory depression, and decreased alertness 7
Common Pitfalls to Avoid
- Assuming tramadol is "safer" than traditional opioids: Despite being a weak opioid, tramadol carries specific pregnancy risks including placental transfer and neonatal withdrawal
- Failing to plan for neonatal monitoring: Any infant exposed to chronic tramadol requires at least 3 days of hospital observation for withdrawal symptoms 5
- Abrupt discontinuation: In women already dependent on tramadol, sudden cessation can cause maternal withdrawal that may harm both mother and fetus
- Overlooking the indication bias: Women requiring tramadol during pregnancy often have underlying conditions (chronic pain, other comorbidities) that themselves may contribute to adverse outcomes
The weight of evidence, particularly the FDA drug label warnings and documented cases of neonatal harm, supports avoiding tramadol during pregnancy whenever possible.